Skip to content

Drug interactions

Deferasirox + Pioglitazone

Severity: Minor

Deferasirox and Pioglitazone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Deferasirox can induce CYP3A4 and inhibit CYP2C8, so effects on pioglitazone exposure are uncertain. Changes in glycemic control are possible but probably small.

What this interaction means in plain words

Deferasirox and Pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Deferasirox belongs to Miscellaneous; Pioglitazone belongs to Endocrine.

Evidence level: Low

Why it happens

Modulation of CYP enzymes, mainly CYP2C8 inhibition and CYP3A4 induction, may alter pioglitazone exposure.

What to do

Monitor glucose when deferasirox is started or stopped. Adjust the pioglitazone dose if control or edema changes.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Deferasirox and Pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Deferasirox with Pioglitazone?

MediHelp rates the interaction as minor. Deferasirox and Pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Deferasirox can induce CYP3A4 and inhibit CYP2C8, so effects on pioglitazone exposure are uncertain. Changes in glycemic control are possible but probably small.

How serious is the interaction between Deferasirox and Pioglitazone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor glucose when deferasirox is started or stopped. Adjust the pioglitazone dose if control or edema changes.

What other medicines interact with Pioglitazone?

MediHelp also lists interactions of Pioglitazone with, for example, Insulin aspart-insulin aspart protamine, Insulin aspart, Insulin degludec-insulin aspart. The full list is on the Pioglitazone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in